Refine Results
- Products
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 6 of 6 results
The Agilent AdvanceBio SEC column together with the Agilent 1260 Infinity II Bio-inert System is an ideal combination for the aggregate analysis of ADCs
Size exclusion chromatography/mass spectrometry analysis of antibody drug conjugates using the Agilent 1260 Infinity II Bio-Inert LC
Fraction analysis of cysteine-linked antibody-drug conjugates using hydrophobic interaction chromatography on the Agilent 1260 Infinity II Bio-Inert LC system.
This application note demonstrates the drug-to-antibody (DAR) determination of brentuximab vedotin using a ternary gradient with the Agilent Infinity II Prime Bio LC.
This application note demonstrates the DAR determination of brentuximab vedotin using HIC.
Determination of drug to antibody ratio of brentuximab vedotin using hydrophobic interaction chromatography on the Agilent 1260 Infinity II Bio-inert LC